ondansetron and ranitidine

ondansetron has been researched along with ranitidine in 25 studies

Research

Studies (25)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	5 (20.00)	18.2507
2000's	8 (32.00)	29.6817
2010's	11 (44.00)	24.3611
2020's	1 (4.00)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Lombardo, F; Obach, RS; Waters, NJ	1
He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Sun, Y; Yan, Z	1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K	1
Giacomini, KM; Huang, Y; Khuri, N; Kido, Y; Kosaka, A; Morrissey, KM; Sali, A; Wittwer, MB; Zhang, X; Zur, AA	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Artursson, P; Mateus, A; Matsson, P	1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Bojarski, AJ; Dehaen, W; Janousek, J; Juza, R; Karasova, JZ; Kobrlova, T; Korabecny, J; Kubacka, M; Mezeiova, E; Mogilski, S; Musilek, K; Pejchal, J; Petrasek, T; Prchal, L; Randakova, A; Satala, G; Soukup, O; Stark, H; Stefkova-Mazochova, K; Svozil, D; Vlcek, P; Vojtechova, I	1
Langer, JC; Liebman, SM; Monk, PK; Pelletier, GJ	1
Burm, JP; Chin, A; Fox, JL; Gill, MA; Jeong, E; Jhee, SS; Moon, YS; Nii, L	1
Burm, JP; Fox, JL; Gill, MA; Inagaki, K; Jhee, S; Pompilio, FM	1
Gan, LS; Hsyu, PH; Pritchard, JF; Thakker, D	1
Bye, A; Keene, ON; Lacey, LF; Pritchard, JF	1
Abanmy, NO; Radwan, MA; Zaghloul, IY	1
de Camargo, B; del Giglio, A; Lajolo, PP	1
Trepanier, L	1
Carrasco, MM; Cruz, FM; da Costa Miranda, M; da Cunha Vieira, M; de Afonseca, SO; de Iracema Gomes Cubero, D; de Souza Fêde, AB; del Giglio, A; Lera, AT; Lerner, T; Pinczowski, H; Schindler, F; Taranto, P	1
N'Da, CI; Petzer, A; Petzer, JP	1

Reviews

2 review(s) available for ondansetron and ranitidine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Acute vomiting in cats: rational treatment selection. Journal of feline medicine and surgery, 2010, Volume: 12, Issue:3 Topics: Acute Disease; Animals; Antiemetics; Cat Diseases; Cats; Chlorpromazine; Diarrhea; Famotidine; Indoles; Metoclopramide; Nausea; Ondansetron; Prochlorperazine; Quinolizines; Quinuclidines; Ranitidine; Sucralfate; Vomiting; Weight Loss	2010

Trials

2 trial(s) available for ondansetron and ranitidine

Article	Year
Omission of day 2 of antiemetic medications is a cost saving strategy for improving chemotherapy-induced nausea and vomiting control: results of a randomized phase III trial. American journal of clinical oncology, 2009, Volume: 32, Issue:1 Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cost Savings; Dexamethasone; Double-Blind Method; Doxorubicin; Epirubicin; Female; Humans; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Prognosis; Prospective Studies; Ranitidine; Treatment Outcome; Vomiting	2009
Gabapentin for the prevention of chemotherapy- induced nausea and vomiting: a pilot study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2012, Volume: 20, Issue:3 Topics: Amines; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cyclohexanecarboxylic Acids; Dexamethasone; Double-Blind Method; Female; GABA Antagonists; Gabapentin; gamma-Aminobutyric Acid; Humans; Injections, Intravenous; Male; Middle Aged; Nausea; Ondansetron; Pilot Projects; Prospective Studies; Ranitidine; Vomiting	2012

Article

Year

Omission of day 2 of antiemetic medications is a cost saving strategy for improving chemotherapy-induced nausea and vomiting control: results of a randomized phase III trial.

American journal of clinical oncology, 2009, Volume: 32, Issue:1

Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cost Savings; Dexamethasone; Double-Blind Method; Doxorubicin; Epirubicin; Female; Humans; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Prognosis; Prospective Studies; Ranitidine; Treatment Outcome; Vomiting

2009

Gabapentin for the prevention of chemotherapy- induced nausea and vomiting: a pilot study.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2012, Volume: 20, Issue:3

Topics: Amines; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cyclohexanecarboxylic Acids; Dexamethasone; Double-Blind Method; Female; GABA Antagonists; Gabapentin; gamma-Aminobutyric Acid; Humans; Injections, Intravenous; Male; Middle Aged; Nausea; Ondansetron; Pilot Projects; Prospective Studies; Ranitidine; Vomiting

2012

Other Studies

21 other study(ies) available for ondansetron and ranitidine

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Cheminformatic models to predict binding affinities to human serum albumin. Journal of medicinal chemistry, 2001, Dec-06, Volume: 44, Issue:25 Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids	2001
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
First-principle, structure-based prediction of hepatic metabolic clearance values in human. European journal of medicinal chemistry, 2009, Volume: 44, Issue:4 Topics: Computational Biology; Drug Discovery; Hepatocytes; Humans; Hydrogen-Ion Concentration; Liver; Metabolic Clearance Rate; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship; Sensitivity and Specificity; Software	2009
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1. Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19 Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship	2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
QSAR-based permeability model for drug-like compounds. Bioorganic & medicinal chemistry, 2011, Apr-15, Volume: 19, Issue:8 Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2011
Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling. Journal of medicinal chemistry, 2013, Feb-14, Volume: 56, Issue:3 Topics: Computer Simulation; Fluorescent Dyes; Organic Cation Transport Proteins; Prescription Drugs	2013
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
A high-throughput cell-based method to predict the unbound drug fraction in the brain. Journal of medicinal chemistry, 2014, Apr-10, Volume: 57, Issue:7 Topics: Animals; Brain; Dialysis; HEK293 Cells; High-Throughput Screening Assays; Humans; Pharmaceutical Preparations; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization	2014
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development. Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics	2010
Novel D European journal of medicinal chemistry, 2022, Mar-15, Volume: 232 Topics: Animals; Antipsychotic Agents; Piperazines; Rats; Rats, Wistar; Receptors, Serotonin; Schizophrenia	2022
Mast cell mediators and peritoneal adhesion formation in the rat. The Journal of surgical research, 1995, Volume: 59, Issue:3 Topics: Animals; Azepines; Disease Models, Animal; Histamine Antagonists; Leukotriene D4; Male; Mast Cells; Methysergide; Ondansetron; Peritoneal Diseases; Platelet Activating Factor; Propionates; Pyrilamine; Quinolines; Ranitidine; Rats; Rats, Sprague-Dawley; Serotonin Antagonists; Tissue Adhesions; Triazoles	1995
Stability of paclitaxel with ondansetron hydrochloride or ranitidine hydrochloride during simulated Y-site administration. American journal of hospital pharmacy, 1994, May-01, Volume: 51, Issue:9 Topics: Chromatography, High Pressure Liquid; Drug Stability; Ondansetron; Paclitaxel; Ranitidine; Solutions; Temperature	1994
Stability of ranitidine hydrochloride with ondansetron hydrochloride or fluconazole during simulated Y-site administration. American journal of hospital pharmacy, 1994, Feb-01, Volume: 51, Issue:3 Topics: Chromatography, High Pressure Liquid; Drug Combinations; Drug Incompatibility; Drug Stability; Fluconazole; Hydrogen-Ion Concentration; Ondansetron; Ranitidine; Solutions	1994
Mechanism of intestinal absorption of ranitidine and ondansetron: transport across Caco-2 cell monolayers. Pharmaceutical research, 1993, Volume: 10, Issue:12 Topics: Biological Availability; Biological Transport, Active; Calcium; Cell Line; Culture Media; Diffusion; Humans; Intestinal Absorption; Ondansetron; Permeability; Ranitidine	1993
Common noncompartmental pharmacokinetic variables: are they normally or log-normally distributed? Journal of biopharmaceutical statistics, 1997, Volume: 7, Issue:1 Topics: Bismuth; Body Fluid Compartments; Data Interpretation, Statistical; Humans; Normal Distribution; Ondansetron; Pharmacokinetics; Randomized Controlled Trials as Topic; Ranitidine; Sumatriptan	1997
Compatibility of tramadol hydrochloride injection with selected drugs and solutions. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2005, Jun-15, Volume: 62, Issue:12 Topics: Acyclovir; Ampicillin; Chromatography, High Pressure Liquid; Clindamycin; Contraindications; Drug Incompatibility; Drug Stability; Injections; Ondansetron; Ranitidine; Solutions; Sulbactam; Technology, Pharmaceutical; Tramadol	2005
The inhibition of acetylcholinesterase by dantrolene and ondansetron. Drug research, 2015, Volume: 65, Issue:1 Topics: Antiemetics; Cholinesterase Inhibitors; Dantrolene; Erythrocytes; Humans; Inhibitory Concentration 50; Muscle Relaxants, Central; Ondansetron; Ranitidine; Tacrine	2015